Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer: Practical Training on Individualizing CDK4/6 Inhibitor Treatment to Enhance Adherence, Quality of Life, and Outcomes

Chair Stephanie L. Graff, MD, FACP, FASCO, discusses breast cancer in this CME/MOC/NCPD/CPE/AAPA/IPCE activity titled “Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer: Practical Training on Individualizing CDK4/6 Inhibitor Treatment to Enhance Adherence, Quality of Life, and Outcomes.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4bXeSYU. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 16, 2025.Read less